Compared with the control group, there was no significant difference in body weight change (%) among the groups that were administered different natural products (Fig
Neither class produces lasting benefit after discontinuation for most patients
None of the evidence reported in these papers is close to being convincing, and we would need extraordinary data to overcome the lack of plausibility for these patches working in the first place
Hence, one potential explanation for the increased efficacy of tirzepatide on glycemic control relative to the monoagonist GLP-1RA is that targeting both incretin receptors maintains some insulinotropic activity even in subjects who are relatively insensitive to GLP-1
J Clin Pharm Ther 39(5):564566 Chagas MHN, Zuardi AW, Tumas V, Pena-Pereira MA, Sobreira ET, Bergamaschi MM et al (2014b) Effects of cannabidiol in patients with Parkinsons disease